These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9145070)

  • 21. Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer.
    Barone JE; Tucker JB; Perez JM; Odom SR; Ghevariya V
    Am Surg; 2005 Jan; 71(1):66-70. PubMed ID: 15757061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer.
    Petrik DW; McCready DR; Sawka CA; Goel V
    J Surg Oncol; 2003 Feb; 82(2):84-90. PubMed ID: 12561062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
    J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T1 breast carcinoma in women 70 years of age and older may not require axillary lymph node dissection.
    Feigelson BJ; Acosta JA; Feigelson HS; Findley A; Saunders EL
    Am J Surg; 1996 Nov; 172(5):487-9; discussion 489-90. PubMed ID: 8942550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of lymphatic mapping on diagnosis and treatment of patients with T1a, T1b favorable breast cancer.
    Jakub JW; Ebert MD; Diaz NM; Cantor A; Reintgen DS; Dupont EL; Shons AR; Cox CE
    Ann Surg; 2003 Jun; 237(6):838-41; discussion 841-3. PubMed ID: 12796580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T1a breast carcinoma and the role of axillary dissection.
    Schneidereit NP; Davis N; Mackinnon M; Speers CH; Truong PT; Olivotto IA
    Arch Surg; 2003 Aug; 138(8):832-7. PubMed ID: 12912740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel approach to T classification in tumor-node-metastasis staging of breast cancer.
    Coburn NG; Clarke-Pearson E; Chung MA; Law C; Fulton J; Cady B
    Am J Surg; 2006 Oct; 192(4):434-8. PubMed ID: 16978944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.
    Gipponi M; Canavese G; Lionetto R; Catturich A; Vecchio C; Sapino A; Friedman D; Cafiero F
    Eur J Surg Oncol; 2006 Mar; 32(2):143-7. PubMed ID: 16300921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging.
    Vanderveen KA; Schneider PD; Khatri VP; Goodnight JE; Bold RJ
    Ann Surg Oncol; 2006 Nov; 13(11):1450-6. PubMed ID: 17009150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of axillary lymph node metastases in women with early breast cancer in Singapore.
    Tan LG; Tan YY; Heng D; Chan MY
    Singapore Med J; 2005 Dec; 46(12):693-7. PubMed ID: 16308642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
    Louis-Sylvestre C; Clough K; Asselain B; Vilcoq JR; Salmon RJ; Campana F; Fourquet A
    J Clin Oncol; 2004 Jan; 22(1):97-101. PubMed ID: 14701770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
    Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
    Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel lymph node metastases detected by immunohistochemistry only do not mandate complete axillary lymph node dissection in breast cancer.
    Gray RJ; Pockaj BA; Conley CR
    Ann Surg Oncol; 2004 Dec; 11(12):1056-60. PubMed ID: 15545503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible?
    Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Toyoshima S
    Eur J Surg; 2000 Aug; 166(8):610-5. PubMed ID: 11003428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
    Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
    J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.
    Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL
    Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.
    Kuerer HM; Newman LA; Buzdar AU; Dhingra K; Hunt KK; Buchholz TA; Binkley SM; Strom EA; Ames FC; Ross MI; Feig BW; McNeese MD; Hortobagyi GN; Singletary SE
    Cancer J Sci Am; 1998; 4(4):230-6. PubMed ID: 9689981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.